Antinuclear Antibody Testing Market worth USD 1,476.1 Million USD by 2021

1
MarketsandMarkets Presents
Antinuclear Antibody Testing Market worth USD
1,476.1 Million USD by 2021
http//www.marketsandmarkets.com/Market-Reports/an
tinuclear-antibody-test-market-218189007.html
2
The report "Antinuclear Antibody Test Market by
Product (Reagents Assay Kits, Systems,
Software, Services), Technique (Immunofluorescence
, Elisa, Multiplex), Disease (Rheumatoid
Arthritis, SLE), End User (Clinical Labs,
Hospitals) - Forecast to 2021", report provides a
detailed overview of the major drivers,
restraints, challenges, opportunities, current
market trends, and strategies impacting the ANA
testing market, along with revenue estimates
forecasts and market share analysis. Browse 73
market data Tables and 102 Figures spread through
166 Pages and in-depth TOC on "Antinuclear
Antibody Test Market Get The PDF Brochure For
This Report http//www.marketsandmarkets.com/pdf
download.asp?id218189007 The global
antinuclear antibody test market is expected to
reach USD 1,476.1 Million by 2021 from USD 823.5
Million in 2016, at a CAGR of 12.4 from 2016 to
2021.
http//www.marketsandmarkets.com/Market-Reports/an
tinuclear-antibody-test-market-218189007.html
3

• Scope of the Report
• This report categorizes the antinuclear antibody
  test market into the following segments
• Antinuclear Antibody Test Market, by Product
• Reagents Assay Kits
• Systems
• Software Services
•  Antinuclear Antibody Test Market, by Disease 
• Rheumatoid Arthritis
• Systemic Lupus Erythematosus
• Sjögrens Syndrome
• Scleroderma
• Other Diseases
• Antinuclear Antibody Test Market, by Technique
• ELISA
• Immunofluorescence Assay
• Multiplex Assay
•  
•  Request Sample of the report
• http//www.marketsandmarkets.com/requestsample.asp
  ?id218189007

http//www.marketsandmarkets.com/Market-Reports/an
tinuclear-antibody-test-market-218189007.html
4
Industry Insights Based on products, the
antinuclear antibody test market is segmented
into assay kits reagents, systems, and software
services. The assay kits reagents segment is
expected to account for the largest share of the
global ANA testing market in 2016. The growth in
this segment can majorly be attributed to the
growth in the number of reagent rental agreements
and increasing prevalence of autoimmune
diseases. The antinuclear antibody test market
is segmented into five major disease segments,
namely, rheumatoid arthritis, systemic lupus
erythematosus, Sjögrens syndrome, scleroderma,
and other diseases. Other diseases include
Raynauds Syndrome, polymyositis, mixed
connective tissue disease, drug-induced lupus,
and autoimmune hepatitis. The rheumatoid
arthritis segment is expected to account for the
largest market share, primarily due to the
increasing incidence of rheumatoid
arthritis. Based on techniques, the antinuclear
antibody test market is segmented into
enzyme-linked immunosorbent assay (ELISA),
immunofluorescence assay (IFA), and multiplex
assay. The ELISA segment is expected to account
for the largest share of this market due to the
expanding applications of ANA in autoimmune
disease testing and therapeutic drug level
monitoring.
http//www.marketsandmarkets.com/Market-Reports/an
tinuclear-antibody-test-market-218189007.html
5
Industry Leaders   The major players in this
market include Alere Inc. (U.S.), Bio-Rad
Laboratories, Inc. (U.S.), ERBA Diagnostics, Inc.
(U.S.), Trinity Biotech plc (Ireland), Thermo
Fisher Scientific, Inc. (U.S.), Antibodies, Inc.
(U.S.), EUROIMMUN AG (Germany), Immuno Concepts
(U.S.), Inova Diagnostics (U.S.), and Zeus
Scientific, Inc. (U.S.). Geographical Scenario
  North America is the largest regional segment
in the ANA testing market, followed by Europe,
Asia, and the Rest of the World (RoW). Growth in
the North American market is primarily driven by
the high incidence of autoimmune diseases,
growing population and healthcare spending, and
growth in the number of individuals covered under
medical insurance in the U.S.
http//www.marketsandmarkets.com/Market-Reports/an
tinuclear-antibody-test-market-218189007.html
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.   MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
http//www.marketsandmarkets.com/Market-Reports/an
tinuclear-antibody-test-market-218189007.html
7
Contact Us
Mr. Rohan MarketsandMarkets 701 Pike Street
Suite 2175, Seattle, WA 98101, United States
Tel [phone] Email sales_at_marketsandmarket
s.com MarketsandMarkets Bloghttp//www.marketsan
dmarkets.comhttp//twitter.com/marketsmarkets htt
p//www.linkedin.com/company/marketsandmarkets